These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10334038)

  • 1. The interaction of mitogen-activated protein kinases to Epstein-Barr virus activation in Akata cells.
    Satoh T; Hoshikawa Y; Satoh Y; Kurata T; Sairenji T
    Virus Genes; 1999; 18(1):57-64. PubMed ID: 10334038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway.
    Fahmi H; Cochet C; Hmama Z; Opolon P; Joab I
    J Virol; 2000 Jul; 74(13):5810-8. PubMed ID: 10846060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphatidylinositol 3-kinase is a determinant of responsiveness to B cell antigen receptor-mediated Epstein-Barr virus activation.
    Iwakiri D; Takada K
    J Immunol; 2004 Feb; 172(3):1561-6. PubMed ID: 14734735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular immediate-early gene expression occurs kinetically upstream of Epstein-Barr virus bzlf1 and brlf1 following cross-linking of the B cell antigen receptor in the Akata Burkitt lymphoma cell line.
    Ye J; Gradoville L; Miller G
    J Virol; 2010 Dec; 84(23):12405-18. PubMed ID: 20861250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Epstein-Barr virus by saliva from Sjogren's syndrome patients.
    Nagata Y; Inoue H; Yamada K; Higashiyama H; Mishima K; Kizu Y; Takeda I; Mizuno F; Hayashi Y; Saito I
    Immunology; 2004 Feb; 111(2):223-9. PubMed ID: 15027908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Epstein-Barr virus-induced Ca2+/calmodulin-dependent kinase type IV/Gr promotes a Ca(2+)-dependent switch from latency to viral replication.
    Chatila T; Ho N; Liu P; Liu S; Mosialos G; Kieff E; Speck SH
    J Virol; 1997 Sep; 71(9):6560-7. PubMed ID: 9261377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of genistein, a tyrosine kinase inhibitor, on latent EBV activation induced by cross-linkage of membrane IgG in Akata B cells.
    Daibata M; Mellinghoff I; Takagi S; Humphreys RE; Sairenji T
    J Immunol; 1991 Jul; 147(1):292-7. PubMed ID: 1711079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases.
    Adamson AL; Darr D; Holley-Guthrie E; Johnson RA; Mauser A; Swenson J; Kenney S
    J Virol; 2000 Feb; 74(3):1224-33. PubMed ID: 10627532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of protein tyrosine kinases required for B-cell- receptor-mediated activation of an Epstein-Barr Virus immediate-early gene promoter.
    Lavens S; Faust EA; Lu F; Jacob M; Leta M; Lieberman PM; Puré E
    J Virol; 2004 Aug; 78(16):8543-51. PubMed ID: 15280463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Epstein-Barr virus (EBV) reactivation by short interfering RNAs targeting p38 mitogen-activated protein kinase or c-myc in EBV-positive epithelial cells.
    Gao X; Wang H; Sairenji T
    J Virol; 2004 Nov; 78(21):11798-806. PubMed ID: 15479821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The mechanisms of Epstein-Barr virus activation in B cells].
    Sairenji T
    Nihon Rinsho; 1997 Feb; 55(2):316-20. PubMed ID: 9046817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA.
    Daibata M; Humphreys RE; Sairenji T
    Virology; 1992 Jun; 188(2):916-20. PubMed ID: 1316687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of interleukin-10 on activation of Epstein-Barr virus in EBV-infected B-cell lines.
    Sairenji T; Ohnishi E; Inouye S; Kurata T
    Viral Immunol; 1998; 11(4):221-31. PubMed ID: 10189189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
    Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
    J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCAAT/enhancer binding protein alpha interacts with ZTA and mediates ZTA-induced p21(CIP-1) accumulation and G(1) cell cycle arrest during the Epstein-Barr virus lytic cycle.
    Wu FY; Chen H; Wang SE; ApRhys CM; Liao G; Fujimuro M; Farrell CJ; Huang J; Hayward SD; Hayward GS
    J Virol; 2003 Jan; 77(2):1481-500. PubMed ID: 12502863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of cell growth and Epstein-Barr virus reactivation by CD40 stimulation in Epstein-Barr virus-transformed B cells.
    Fukuda M; Satoh TA; Takanashi M; Hirai K; Ohnishi E; Sairenji T
    Viral Immunol; 2000; 13(2):215-29. PubMed ID: 10893001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct patterns of mitogen-activated protein kinase phosphorylation and Epstein-Barr virus gene expression in Burkitt's lymphoma cell lines versus B lymphoblastoid cell lines.
    Satoh T; Fukuda M; Sairenji T
    Virus Genes; 2002; 25(1):15-21. PubMed ID: 12206304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Promotes EBV Reactivation through Activation of the p38 Mitogen-Activated Protein Kinase.
    Liu X; Cohen JI
    J Virol; 2016 Jan; 90(2):1129-38. PubMed ID: 26559845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Stat1 and subsequent transcription of inducible nitric oxide synthase gene in C6 glioma cells is independent of interferon-gamma-induced MAPK activation that is mediated by p21ras.
    Nishiya T; Uehara T; Edamatsu H; Kaziro Y; Itoh H; Nomura Y
    FEBS Lett; 1997 May; 408(1):33-8. PubMed ID: 9180263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent requirements for the MAPK(ERK) signal transduction pathway during initial virus infection of quiescent primary B cells and disruption of Epstein-Barr virus latency by phorbol esters.
    Fenton M; Sinclair AJ
    J Virol; 1999 Oct; 73(10):8913-6. PubMed ID: 10482653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.